Teva-Cotridin (2020-06-01)
- Starting date:
- June 1, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-73273
Last updated: 2020-06-09
Summary
-
Product:
Teva-Cotridin Syrup
Reason
Affected lots contain Codeine Phosphate levels outside of the labelled claim.
Depth of distribution
Wholesalers, Retailers
Affected products
Teva-Cotridin Syrup
DIN, NPN, DIN-HIM
DIN 02169126
Dosage form
Syrup
Strength
- Codeine phosphate 10 mg/5 mL
- Pseudoephedrine hydrochloride 30 mg/5 mL
- Triprolidine hydrochloride 2 mg/5 mL
Lot or serial number
680026, 680046
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA